|
|
As the technological advancement of next generation sequencers (NGS) has been so rapid, we are now truly entering the era of "$1000 genome". This rapid progression of NGS capacity allows us to perform a large-scale sample analysis, especially in the medical field such as cancer and hereditary diseases, which have yielding many clinically applicable findings. We could say that genomics is now entering the phase of the field test. Even in Japan, there are some moves toward practical application of the genomics such as DTC genome analysis and cancer genome sequencing for identifying the therapeutic targets. At the same time, the advancement of the application of NGS is expanding rapidly. Thus, advancements such as single cell and new data analysis are now accelerating at high speed and bringing up a new finding that can be applicable in clinic and the other fields. We could finally envisage the road toward the personalized medicine in the future of genome technologies.
The 11th International Workshop on Advanced Genomics (11AGW) to be held from May 20th to 22nd, 2015. The theme of it is "My genome, Your genome - Grand challenges for personal and single cell genome sequencing." It will cover various frontiers of genome research including "Personal Genome and Inherited Disease," "Cancer Genome," "Epigenome and non-coding RNA," "Metagenome and Human Microbiome" and "Population Genomics," as well as "New Technology." The organizing committee wishes to invite wide range of participants from various field of experts both from academia and from industries. The workshop is organized by the 164th Committee of Japan Society for the Promotion of Science (JSPS), and is supported by Japan Bioindustry Association (JBA), Japan Biological Informatics Consortium (JBIC), Japan Health Sciences Foundation and the Federation of Pharmaceutical Manufacturers' Associations of Japan.
Prof. Sumio Sugano,
Chairperson of Organizing Committee
Prof. Hiroyuki Aburatani,
Chairperson of Program Committee
|
|
| Gold Sponsor |
 |
| Silver Sponsor |
 |
|
